Drugs / Cal-1 modified HSPC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01734850 | Apr 2013 → Sep 2017 | HIV infectious disease | Calimmune, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cal-1 modified HSPC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01734850 ↗ |
| Action | Inhibit | “Cal-1 is an experimental gene transfer agent designed to inhibit HIV infection” NCT01734850 ↗ |